RBC Capital analyst Leonid Timashev reiterated a Sector Perform rating and $5.00 price target on Design Therapeutics Inc (NASDAQ: DSGN).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE